Table 1.

Baseline characteristics of the ENHANCE participants overall, and by treatment arm

Characteristic	Overall		Technology-Supported Behavioral Intervention (n=131)		Attention Control (n=132)		p-valueb
	n	%	n	%	n	%
Age (in years)							0.88
25-34	11	4.2	6	4.6	5	3.8
35-44	27	10.3	16	12.2	11	8.3
45-54	76	28.9	36	27.5	40	30.3
55-64	100	38.0	47	35.9	53	40.2
65-74	38	14.4	20	15.3	18	13.6
>= 75	11	4.2	6	4.6	5	3.8
Female	179	68.1	93	71.0	86	65.2	0.31
White	184	70.0	90	68.7	94	71.2	0.66
Married or living with partner	137	52.3	67	51.5	70	53.0	0.81
Health care Insurance	244	93.5	121	93.1	123	93.9	0.79
Employed	153	58.4	76	58.5	77	58.3	0.98
Any post-high school education	181	69.1	87	66.9	94	71.2	0.45
Duration of diabetes							0.41
Less than a year	57	21.8	28	21.4	29	22.1
1-5 years	107	40.8	49	37.4	58	44.3
More than 5 years	98	37.4	54	41.2	44	33.6
A1c & eGFR							0.67
A1c < 8%, eGFR ≥ 60 ml/min	157	59.7	75	57.3	82	62.1
A1c ≥ 8%, eGFR ≥ 60 ml/min	74	28.1	40	30.5	34	25.8
eGFR < 60 ml/min	32	12.2	16	12.2	16	12.1
Diabetes medicationsa	226	90.4	115	91.3	111	89.5	0.64
Antihypertensive medicationsa	173	69.2	85	67.5	88	71.0	0.55
Lipid lowering medicationsa	141	56.4	72	57.1	69	55.6	0.81

^aMedication data missing for 5 Technology-Supported Behavioral Intervention and 8 Attention Control participants

^bp-values computed using Pearson Chi-square test